Objective- To communicate interim guidelines for noninvasive ventilatory support in COVID-19 pandemic.
With intensive care units (ICUs) overwhelmed during the current coronavirus disease of 2019 (COVID-19) pandemic, many hospitals have turned to noninvasive ventilation (NIV) to stave off severe respiratory failure and ease the pressure on limited resources.
- For continuous positive airway pressure (CPAP) and high-flow nasal cannula (HFNC) to slow disease progression, the hospital should use CPAP, bilevel positive airway pressure (BiPAP) and NIV devices for treatment.
- European Society of Intensive Care Medicine (ESICM) advises the use of oxygen delivered by HFNC as first-line therapy for patients with COVID-19 and for acute hypoxemic respiratory failure in preference to noninvasive positive-pressure ventilation (NIPPV)/CPAP. The CPAP could be used with close monitoring and short-interval assessment for worsening respiratory failure.
- CPAP is extremely beneficial for reducing ICU admissions
- CPAP also reduces the number of patients requiring intubation because nurses can administer it.
References: Noninvasive Ventilatory Support in COVID-19: Friend or Foe? Available from: https://www.medscape.com/viewarticle/928259. Accessed on May 7, 2020.